Trademark: 97771180
Status Date
Tuesday, March 5, 2024
Filing Date
Friday, January 27, 2023
Published for Opposition
Tuesday, January 9, 2024
5 Pharmaceutical preparations, namely, those for use in human oncology; Tyrosine kinase inhibitors for use in the treatment of cancer; Drugs in the nature of pharmaceutical preparations for use in treating chronic myelogenous leukemia
Mar 5, 2024
Noa E-Mailed - Sou Required From Applicant
Jan 9, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 9, 2024
Published For Opposition
Dec 20, 2023
Notification Of Notice Of Publication E-Mailed
Dec 1, 2023
Approved For Pub - Principal Register
Nov 10, 2023
Teas/Email Correspondence Entered
Nov 9, 2023
Correspondence Received In Law Office
Nov 9, 2023
Teas Response To Office Action Received
Aug 7, 2023
Application Extension Granted/Receipt Provided
Aug 7, 2023
Application Extension To Response Period - Received
May 9, 2023
Notification Of Non-Final Action E-Mailed
May 9, 2023
Non-Final Action E-Mailed
May 9, 2023
Non-Final Action Written
May 8, 2023
Notification Of Non-Final Action E-Mailed
May 8, 2023
Non-Final Action E-Mailed
May 8, 2023
Non-Final Action Written
May 2, 2023
Assigned To Examiner
Feb 15, 2023
New Application Office Supplied Data Entered
Jan 31, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
